The sensitivity of car:iitine palmitoyltransferase I to inhibition by 4-hydroxyphenylglyoxylate was decreased markedly in liver mitochondria isolated from either 48 h-starved or streptozotocin-diabetic rats. These treatments of the rat also decreased the sensitivity of fatty acid oxidation by isolated hepatocytes to inhibition by this compound. Furthermore, incubation of hepatocytes prepared from fed rats with N602'-dibutyryl cyclic AMP also decreased the sensitivity, whereas incubation of hepatocytes prepared from starved rats with lactate plus pyruvate had the opposite effect on 4-hydroxyphenylglyoxylate inhibition of fatty acid oxidation. The sensitivity of carnitine palmitoyltransferase I of mitochondria to 4-hydroxyphenylglyoxylate increased in a time-dependent manner, as previously reported for malonyl-CoA. Likewise, oleoyl-CoA activated carnitine palmitoyltransferase I in a time-dependent manner and prevented the sensitization by 4-hydroxyphenylglyoxylate. Increased exogenous carnitine caused a moderate increase in fatty acid oxidation by hepatocytes under some conditions and a decreased 4-hydroxyphenylglyoxylate inhibition of fatty acid oxidation at low oleate concentration, without decreasing the difference in 4-hydroxyphenylglyoxylate inhibition between fed-and starved-rat hepatocytes. Time-dependent changes in the conformation of carnitine palmitoyltransferase I or the membrane environment may be involved in differences among nutritional states in 4-hydroxyphenylglyoxylate-sensitivity of carnitine palmitoyltransferase I.
INTRODUCTION
Carnitine palmitoyltransferase I (CPT I), an important regulatory enzyme of fatty acid oxidation (McGarry & Foster, 1980) , is inhibited by malonyl-CoA, an intermediate of fatty acid synthesis in the liver. However, malonyl-CoA concentration may not be the sole regulatory factor for fatty acid oxidation. Indeed, changes in sensitivity of CPT I to inhibition by malonyl-CoA may also be important in starvation and diabetes (Cook et al., 1984) . The mechanism responsible for this change in sensitivity to malonyl-CoA inhibition is unknown. Physiological conditions have been observed where variations in malonyl-CoA concentration were insufficient to explain fatty acid oxidation capacity (Benito & Williamson, 1978) , and a wide range of fatty acid oxidation rates has been observed over a narrow range of malonyl-CoA concentrations (Boyd et al., 1981) . A major obstacle to such investigations is the inability to vary intracellular malonyl-CoA concentrations readily and specifically. Additionally, rate limitation or high control strength (Kacser & Burns, 1973) of liver fatty acid oxidation by CPT I has been confirmed by some (McGarry & Foster, 1973; Cook et al., 1980; Harano et al., 1982) and questioned by others (Brass & Hoppel, 1980) . With respect to mechanism, Zammit (1984) has proposed that CPT I of mitochondria isolated from rats in various nutritional states may differ in sensitivity to malonyl-CoA inhibition, owing to 'memory' of the malonyl-CoA concentration in vivo. Bremer et al. (1985) have verified the slow sensitization process and demonstrated that KCI and palmitoyl-CoA enhance a desensitization/activation process. The possiblity that conditions during the isolation of mitochondria (malonyl-CoA concentration, acyl-CoA concentration, ionic strength and temperature) may alter the sensitivity of CPT I to malonyl-CoA inhibition makes a method where sensitivity can be studied in intact cells desirable. Covalent phosphorylation of a catalytic subunit of CPT I, resulting in a lower Km for acyl-CoA and consequently a higher Ki for malonyl-CoA, is another possible mechanism for sensitivity changes (Harano et al., 1985) .
Changes in Ki for malonyl-CoA have been concluded to be responsible for changes in sensitivity to malonyl-CoA inhibition (Cook, 1984b; Gamble & Cook, 1985) .
The current studies use 4-hydroxyphenylglyoxylate (HPG) as an inhibitor of CPT I to study sensitivity changes in CPT I of liver mitochondria and fatty acid oxidation by isolated hepatocytes. This inhibitor was chosen because it has properties similar to those of malonyl-CoA (Stephens et al., 1985) . In contrast with malonyl-CoA, which cannot penetrate the plasma membrane, HPG inhibits fatty acid oxidation when added to the external medium of isolated hepatocytes. With this compound, known modulators of fatty acid oxidation can be incubated with hepatocyte preparations and the sensitivity of fatty acid oxidation to HPG inhibition monitored. HPG was also used to investigate the mechanism of time-dependent changes in sensitivity (Stephens et al., 1985) . Wistar rats (chow-fed or 48 h-starved; 200-250 g) were obtained from Harlan Industries (Indianapolis, IN, U.S.A.). Streptozotocindiabetes was induced by injection of 150 mg of streptozotocin/kg body wt. 48 h before animals were killed (Schein et al., 1971) . Only very ketotic (urine ketone bodies > 40 mg/dl) animals were used for these studies.
Preparation of mitochondria and hepatocytes
Liver mitochondria were prepared essentially as described by Johnson & Lardy (1967) and suspended in 0.25 M-sucrose (adjusted to pH 7.4 with Tris base), except where the final wash was performed in KCI medium, which was 150 mM-KCl, S mM-Tris/HCl and 1 mM-EGTA, pH 7.4 (indicated in Figures) . Respiratory control ratios were determined by measuring 02 consumption with a Clark oxygen electrode, and averaged 9.5, 5.1 and 4.5 for mitochondria isolated from fed, starved and diabetic rats with 10 mM-glutamate plus 0.5 mM-malate as substrates.
Hepatocytes were isolated by the method of Berry & Friend (1969) with modifications described previously (Harris, 1975) .
Hepatocytes were permeabilized with filipin essentially as described by Gankema et al. (1981) , except that filipin was added as a solution in dimethyl sulphoxide to a final concentration of 100 M and cells were incubated at 37°C for 2 min before cooling to ice temperature.
Assay of CPT I
CPT I activity ofliver mitochondria was assayed by the radioisotope method described previously with a 5 min preincubation and 5 min incubation (Stephens et al., 1985) . The complete system (1 ml) contained 0.1 mg of mitochondrial protein, 80 mM-sucrose, 70 mM-KCl, 50 mM-imidazole/HCl (pH 7.0 at 30°C), 1 mM-EGTA, 4 mg of bovine serum albumin, 5 mM-glutathione, 1 jig of antimycin A, 0.5 mM-phenylpyruvate, 50 ,tM-oleoylCoA, 0.2 mM-l-carnitine (2 ,uCi of L-[methyl-3H]carnitine/,umol). The incubation and extraction procedures were modified for studies of the time course for HPG inhibition. Mitochondria suspended in the KCI medium at 20 mg/ml were added to prewarmed preincubation mixture in a 25 ml Erlenmeyer flask. At the desired preincubation times, a sample (1.8 ml) of this mixture was transferred to prewarmed tubes containing 0.2 ml of substrates to initiate the enzymic reaction. Concentrations of components in this reaction mixture were the same as above, except that mitochondrial protein was 1 mg/ml. The reaction was terminated after 15 s by the addition of 4 ml of 1 M-HCl04. The extraction of acid-insoluble acylcarnitines was performed essentially as described by Bremer et al. (1985) , except that the protein pellet was resuspended in 3.5 ml of 75 mmNa2HPO4 saturated with butanol and extracted with 1.0 ml of butanol. The use of (NH4)2SO4 was eliminated in this procedure without significant effect. Results by this extraction procedure were identical with those obtained by the procedure described previously (Stephens et al., 1985) , except that blank radioactivity was decreased.
Assay of CPT I with filipin-permeabilized hepatocytes was performed as described above, except that 0. (McCune & Harris, 1979) . The rate of fatty acid oxidation is expressed in terms of nmol of oleate converted into 14CO2 plus acid-soluble products/min per mg wet wt of hepatocytes. Statistical analysis Data in Table 1 were evaluated for heterogeneity of variance by Bartlett's Chi Square test (Sokal & Rohlf, 1969) . Three-way analysis of variance was performed by the General Linear Model program of the SAS Statistical Package (SAS Institute, Cary, NC, U.S.A.) with reciprocal cell error variances as weighting factors. Individual comparisons of means were made by using the linear contrast option of this program.
RESULTS
Effect of starvation and diabetes on HPG inhibition of CPT I activity of liver mitochondria and fatty acid oxidation by hepatocytes CPT I of liver mitochondria from starved or ketotic-diabetic animals was less sensitive to HPG inhibition than was CPT I of liver mitochondria from normal fed animals ( Fig. 1) . Analogous results are obtained with malonyl-CoA as inhibitor (Cook et al., 1984) . The ability to detect sensitivity changes in CPT I of liver mitochondria with HPG as inhibitor, and the effectiveness of HPG as an inhibitor of fatty acid oxidation by hepatocytes (Stephens et al., 1985) , suggested that HPG could be used to detect changes in CPT I sensitivity within intact hepatocytes.
The same change in inhibitory sensitivity seen with mitochondrial CPT I activity was found when fatty acid oxidation by hepatocytes derived from fed, starved and ketotic-diabetic animals was titrated with HPG ( Fig. 2) Liver mitochondria were isolated from fed (0) (Fig. 3) . This is indicative of a rate-limiting step of CPT I under these conditions (Rognstadt, 1979 Incubation with 4 mM-carnitine at 0.5 mM-oleate increased fatty acid oxidation by 18% (P < 0.01) with hepatocytes from fed rats, but had no significant effect with hepatocytes from starved rats (Table 2) . In contrast, a significant increase (38%, P < 0.01) in fatty acid oxidation rate was seen with the addition of carnitine at 2.0 mM-oleate for starved-, but not for fed-, rat hepatocytes. At 0.5 mM-oleate, carnitine decreased HPG inhibition with hepatocytes from fed rats and totally reversed HPG inhibition with those from starved rats. In spite of this significant decrease in HPG inhibition caused by high concentrations of carnitine, HPG inhibition was still significantly higher with fed-rat hepatocytes than with starved-rat hepatocytes without carnitine supplementation. At 2.0 mM-oleate, carnitine was not effective in decreasing HPG inhibition with hepatocytes from either fed or starved rats.
Effect of Bt2cAMP on HPG inhibition of CPT I activity of filipin-permeabilized hepatocytes Filipin treatment of hepatocytes results in cells which are permeable to low-Mr compounds (Gankema et al., 1981) , making it possible to measure CPT I activity of isolated hepatocytes without isolating mitochondria. Hepatocytes were incubated with and without Bt2cAMP under standard incubation conditions (omitting oleate) and then treated with filipin. CPT I activity was then measured directly without isolation of mitochondria. Bt2cAMP did not affect HPG inhibition of CPT I activity by filipin-treated hepatocytes (Fig. 4) . Filipin treatment led to 100% Trypan Blue permeability and gave acceptable CPT I activity (2 nmol/min per mg of protein for filipin-treated hepatocytes versus 6 nmol/min per mg of protein for isolated mitochondria), which was 95% inhibitable by HPG. These results suggest that filipin-treated hepatocytes were permeable to substrates and that the mitochondria must have remained intact. In spite of the lack of change in sensitivity of HPG inhibition, Bt2cAMP increased CPT I activity by 24%, which is similar to the 27% increase in fatty acid oxidation seen with intact hepatocytes. Glucagon similarly increased CPT I activity without altering HPG inhibition (results not shown).
Vol. 243 Time-dependency of HPG inhibition and CPT I activity of isolated liver mitochondria HPG inhibition of isolated liver mitochondrial CPT I increased from 12.9+4.6% at zero time to .59.7+ 1.6% after preincubation for 10 min in the presence of 20 /SM-HPG (Fig. 5) . Preincubation in the absence of HPG during the same period had no effect on HPG inhibition. Preincubation in the presence of HPG and the absence of oleoyl-CoA is most likely responsible for the significantly higher HPG inhibition observed in Fig. 5 than in Fig. 1 (see the Discussion section).
Preincubation of isolated liver mitochondria in the presence of KCI led to an activation of CPT I (Fig. 6) . KCI plus oleoyl-CoA led to an even greater activation. The addition of HPG prevented activation by KCI in the absence, but not in the presence, of oleoyl-CoA. When data from Fig. 6 were plotted as percentage inhibition by HPG (not shown), oleoyl-CoA, but not carnitine, appeared to prevent the sensitization caused by preincubation with HPG.
DISCUSSION
The decrease in HPG inhibition of liver mitochondrial CPT I resulting from starvation and ketotic diabetes is very similar to that shown previously for malonyl-CoA inhibition (Cook et al., 1984) . HPG inhibition depends on many of the same factors as malonyl-CoA inhibition (Stephens et al., 1983 (Stephens et al., , 1985 . These similarities suggest that sensitivity changes in HPG inhibition of CPT I are analogous to changes in sensitivity to inhibition by malonyl-CoA. On the other hand, HPG inhibition appears competitive with carnitine (Stephens et al., 1985) , whereas malonyl-CoA is competitive with longchain acyl-CoA. More recently, the Km for carnitine has been reported to be increased by malonyl-CoA and the K0.5 for malonyl-CoA increased by carnitine (Bird & Saggerson, 1985) . Unlike malonyl-CoA, the intracellular concentration of HPG can be readily varied (by adding exogenous HPG) to determine effects on fatty acid oxidation. The observation that starvation and ketotic diabetes also decreased the sensitivity to HPG inhibition of fatty acid oxidation by isolated hepatocytes suggests that a common mechanism determines the degree of inhibition in the two experimental systems (mitochondria and hepatocytes) and argues that HPG can be used to titrate CPT I activity in intact hepatocytes. The linearity of the Dixon plot for HPG inhibition of fatty acid oxidation by hepatocytes from fed rats suggests that CPT I is rate-limiting for fatty acid oxidation. The observation that inhibition of CPT I by HPG causes a proportional inhibition in fatty acid oxidation suggests a control strength of 1 for this enzymic step (Kacser & Burns, 1973) . Brass & Hoppel (1980) argued that CPT could not be rate-limiting, on the basis of increased acylcarnitine concentrations in rats injected with carnitine without a concomitant change in blood ketone bodies. McGarry & Foster (1973) , Cook et al. (1980) and Harano et al. (1982) , in agreement with our results, found CPT I to catalyse the apparent ratelimiting step under the conditions studied.
Bt2cAMP and glucagon decreased HPG inhibition of fatty acid oxidation by fed-rat hepatocytes while increasing the overall rate of fatty acid oxidation. Harano et al. (1985) found that Bt2cAMP and glucagon caused a decrease in Km of CPT I for palmitoyl-CoA, an increase in Ki of CPT I for malonyl-CoA, and the phosphorylation of an Mr-69000 anti-CPT immunoprecipitated protein. However, in the present study the decrease in sensitivity of hepatocyte fatty acid oxidation to HPG inhibition by incubation with Bt2cAMP was not found to be accompanied by a decrease in HPGsensitivity of CPT I activity, as assayed in filipin-treated hepatocytes. Total CPT I activity increased to the same extent as fatty acid oxidation increased with intact hepatocytes, suggesting that fatty acid oxidation can be stimulated by a mechanism that does not directly affect HPG sensitivity of CPT I. Saggerson et al. (1981) have reported that mitochondrial fatty acid oxidation can be significantly increased in homogenates of liver perfused with glucagon without affecting malonyl-CoA-sensitivity of CPT I.
Addition of lactate plus pyruvate or glucose to the incubation medium increased HPG inhibition of fatty acid oxidation by starved-rat hepatocytes without affecting the fatty acid oxidation rate. These oxidizable substrates are good precursors for malonyl-CoA formation and have been shown to inhibit fatty acid oxidation as well as to increase malonyl-CoA concentrations in hepatocytes (McGarry & Foster, 1979) . The lack of effect of lactate plus pyruvate or glucose on fatty acid oxidation rate by hepatocytes from starved rats in the present study suggests that malonyl-CoA concentrations were not increased sufficiently by metabolism of these substrates to cause inhibition of fatty acid oxidation. The addition of lactate plus pyruvate may decrease long-chain acyl-CoA by increasing fatty acid esterification (Stakkestad & Lund, 1984) , perhaps resulting in higher sensitivity of CPT I to HPG inhibition. This is supported by the finding that mercaptopicolinate blocks the increase in sensitivity caused by lactate plus pyruvate (results not shown), probably by blocking the formation of glycerol 3-phosphate. Redox effects cannot be ruled out, but are not expected to be a direct factor at a 5: 1 ratio of lactate to pyruvate. Addition of lactate plus pyruvate to the incubation of hepatocytes isolated from fed rats resulted in a small increase in HPG inhibition and a decrease in fatty acid oxidation rate at an oleate concentration of 0.5 mm (Table 1) .
Incubation with carnitine resulted in a small increase in fatty acid oxidation rate under certain conditions. HPG inhibition was decreased when 0.5 mM-oleate, but not 2.0 mM-oleate, was used as substrate. HPG inhibition is competitive with carnitine (Stephens et al., 1985) , and carnitine concentrations have been found either to increase in starvation and diabetes (McGarry et al., 1975) or not to change (Brass & Hoppel, 1980) . By incubating hepatocytes with 4 mM-carnitine during the 30 min preincubation, intracellular concentrations as high as 2 mm can be obtained (Christiansen et al., 1976) . This value is considerably higher than found in vivo in livers of fed, starved or diabetic rats (McGarry et al., 1975) . HPG inhibition remained significantly higher with fed-rat than with starved-rat hepatocytes incubated with carnitine, suggesting that variation in carnitine concentration is not the explanation for the difference in sensitivity of HPG inhibition caused by nutritional state. Reversal of HPG inhibition of hepatocyte fatty acid oxidation by carnitine at low, but not high, oleate concentrations is similar to observed effects of carnitine on malonyl-CoA inhibition of CPT I (Bird & Saggerson, 1985) .
Fatty acid oxidation was more than doubled and HPG inhibition decreased almost to half by increasing oleate concentration from 0.5 to 2.0 mm. Fatty acid oxidation was significantly correlated with HPG inhibition and oleate concentration when varied by starvation, diabetes and chow feeding, suggesting that sensitivity of CPT I to inhibition is a factor in determining fatty acid oxidation rate under these conditions. Inhibition of CPT I activity of isolated mitochondria increased from 15 to 60% after 10 min of incubation in the presence of 20 /M-HPG. Malonyl-CoA inhibition of mitochondrial CPT I activity is also time-dependent (Zammit, 1984) . Oleoyl-CoA caused a rapid activation of mitochondrial CPT I and a decrease in HPG inhibition in the current studies. Bremer et al. (1985) reported that palmitoyl-CoA desensitizes CPT I to malonyl-CoA inhibition. It is important to note here that HPG inhibition was unaffected when oleoyl-CoA concentrations were varied between 25 and 100 gM (Stephens et al., 1985) . For the latter studies, mitochondria had been preincubated with oleoyl-CoA and HPG in a KClcontaining medium for 5 min at 30°C before starting the reaction with carnitine. Therefore, any sensitivity change may have been complete before assay of CPT I activity.
Carnitine did not activate CPT I or affect HPG inhibition in a time-dependent manner in the current studies. Cook (1984a) has concluded that changes in sensitivity of CPT I owing to apparent hysteretic inhibition by malonyl-CoA are of insufficient duration and magnitude to explain the changes seen in sensitivity of mitochondria isolated from fed, starved and ketoticdiabetic animals. However, the degree of time-dependent change in HPG inhibition seen in the present study could account for the observed differences in HPG sensitivity of CPT I activity of mitochondria isolated from fed, starved and diabetic rats (60, 26 and 24% respectively).
Phosphorylation of CPT I might result in some conformational change in the enzyme which is ionicstrength-, temperature-or time-dependent and which results in changes in affinity for substrate or inhibitors. Under the appropriate conditions, any of these factors might account for changes in sensitivity to inhibition by promoting the same conformational change in CPT I.
